Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C2024
http://purl.obolibrary.org/obo/NCIT_C2024
|
|---|---|
| Preferred Name | H-ras Antisense Oligodeoxynucleotide ISIS 2503 |
| Definitions |
A synthetic oligodeoxynucleotide. Functioning as an anti-sense agent, it hybridizes to the translation initiation region of the human mRNA for the oncogene H-Ras. ISIS 2503 selectively inhibits the expression of H-Ras, and may inhibit the growth of some Ras-dependent tumor cells. (NCI04)
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A synthetic oligodeoxynucleotide. Functioning as an anti-sense agent, it hybridizes to the translation initiation region of the human mRNA for the oncogene H-Ras. ISIS 2503 selectively inhibits the expression of H-Ras, and may inhibit the growth of some Ras-dependent tumor cells. (NCI04) |
|---|---|
| prefLabel | H-ras Antisense Oligodeoxynucleotide ISIS 2503
|
| label | H-ras Antisense Oligodeoxynucleotide ISIS 2503
|
| PDQ_Closed_Trial_Search_ID | 37795
|
| code | C2024
|
| prefixIRI | NCIT:C2024
|
| in_subset | |
| Preferred_Name | H-ras Antisense Oligodeoxynucleotide ISIS 2503
|
| FDA_UNII_Code | I444I66XWH
|
| Contributing_Source | FDA
|
| Maps_To | H-ras Antisense Oligodeoxynucleotide ISIS 2503
|
| CAS_Registry | 149957-14-2
|
| NSC Number | 718878
|
| NCI_Drug_Dictionary_ID | 37795
|
| Legacy Concept Name | ISIS_2503
|
| type | |
| ALT_DEFINITION | A substance that is being studied in the treatment of cancer.
|
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 37795
|
| Semantic_Type |
Pharmacologic Substance
Nucleic Acid, Nucleoside, or Nucleotide
|
| UMLS_CUI | C0879385
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |